Development of an inventory of goals using the International Classification of Functioning, Disability and Health in a population of non-ambulatory children and adolescents with cerebral palsy treated with botulinum toxin A
Abstract Background In the management of hypertonicity in children with cerebral palsy (CP), goals should be clearly identified in order to evaluate the effectiveness of botulinum toxin A (BoNT-A) treatment, specifically in non-ambulatory children and adolescents, Gross Motor Function Classification...
Main Authors: | Linda Nguyen, Ronit Mesterman, Jan Willem Gorter |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-01-01
|
Series: | BMC Pediatrics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12887-017-0974-x |
Similar Items
-
Use of botulinum toxin in children with cerebral palsy
by: Monika Stecko, et al.
Published: (2019-07-01) -
The efficiency of high dose botulinum toxin type-A in the treatment of cerebral palsy
by: Alper İbrahim Dai
Published: (2014-03-01) -
Botulinum A toxin utilizations in obstetric palsy
by: Atakan Aydin, et al.
Published: (2012-12-01) -
USE OF BOTULINUM TOXIN TYPE A IN THE TREATMENT OF SPASTICITY IN CHILDREN WITH CEREBRAL PALSY
by: Ljiljana Lazić, et al.
Published: (2011-06-01) -
Use of Botulinum toxin in 55 children with cerebral palsy
by: Mohammadi M
Published: (2000-10-01)